Skip to main content
SpringerLink
Log in
Book cover

Rheumatic Disease pp 159–164Cite as

Antimalarials and Other Second-Line Drugs

  • Chapter

Part of the book series: Treatment in Clinical Medicine ((TC MEDICINE))

Abstract

The use of antimalarials in rheumatoid arthritis has had a chequered history since the publication of controlled studies in the 1950s.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

  • Dubois EL (1978) Antimalarials in the management of discoid and systemic lupus erythematosus. Semin Arthritis Rheum 8: 35–51

    Google Scholar 

  • Laaksonen A, Kosiahole V, Juva K (1974) Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol 3: 103–108

    Article  PubMed  CAS  Google Scholar 

  • MacKenzie AH, Scherbel AL (1980) Chloroquine and hydroxychloroquine in rheumatological therapy. Saunders, Philadelphia London Toronto (Clin Rheum Dis, vol 10, pp 545–566 )

    Google Scholar 

  • Marks JS, Power BJ (1979) Is chloroquine obsolete in treatment of rheumatic disease? Lancet I: 371–373

    Google Scholar 

  • Popert AJ, Meijers KAE, Sharp J, Bier F (1961) Chloroquine diphosphonate in rheumatoid arthritis. Ann Rheum Dis 20: 18–34

    Article  PubMed  CAS  Google Scholar 

  • Rynes RI, Krohel G, Falbo A et al. (1979) Ophthalmologic safety of long term hydroxychlor¬oquine treatment. Arthritis Rheum 22: 832–836

    Article  PubMed  CAS  Google Scholar 

  • Scherbal AL, MacKenzie AH, Nousal JF, Atjidan M (1965) Ocular lesions in rheumatoid arthritis and related diseases with particular reference to retinopathy: a study of 741 patients treated with and without chloroquine drugs. N Engl J Med 273: 360–366

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Rheumatic Diseases, Baird Street, Glasgow, Scotland

    Hilary A. Capell MRCP (Consultant Physician)

  2. Sunderland District General Hospital, Sunderland, England

    T. J. Daymond MRCP, DPhys Med (Consultant Rheumatologist)

  3. University of Newcastle upon Tyne, England

    W. Carson Dick MD, FRCP (Reader in Rheumatology, Consultant Rheumatologist)

  4. Royal Victoria Infirmary, Newcastle upon Tyne, England

    W. Carson Dick MD, FRCP (Reader in Rheumatology, Consultant Rheumatologist)

Authors
  1. Hilary A. Capell MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. J. Daymond MRCP, DPhys Med
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Carson Dick MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Capell, H.A., Daymond, T.J., Dick, W.C. (1983). Antimalarials and Other Second-Line Drugs. In: Rheumatic Disease. Treatment in Clinical Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-3113-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3113-7_17

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-12622-5

  • Online ISBN: 978-1-4471-3113-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation